# Assessing Uniqueness of Inflammatory Bowel Disease Related Microbiome-derived Biomarkers

> **NCT05640583** · NA · COMPLETED · sponsor: **HyGIeaCare, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Irritable Bowel Disease

## Interventions

- **DEVICE:** Hygieacare System

## Key facts

- **NCT ID:** NCT05640583
- **Lead sponsor:** HyGIeaCare, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-16
- **Primary completion:** 2023-03-06
- **Final completion:** 2023-03-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05640583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05640583, "Assessing Uniqueness of Inflammatory Bowel Disease Related Microbiome-derived Biomarkers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05640583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*